(AXON) Axon Enterprise - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US05464C1018
Stock:
Total Rating 49
Risk 86
Buy Signal -0.14
| Risk 5d forecast | |
|---|---|
| Volatility | 61.6% |
| Relative Tail Risk | -24.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.24 |
| Alpha | -29.53 |
| Character TTM | |
|---|---|
| Beta | 1.598 |
| Beta Downside | 0.742 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.11% |
| CAGR/Max DD | 0.65 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 164.0946
Description: AXON Axon Enterprise
Axon Enterprise, Inc. provides public safety technology solutions in the United States and internationally. The company operates in two segments, Software and Sensors, and TASER. The Software and Sensors segment develops, manufactures, and sells integrated hardware and cloud-based software solutions that enable law enforcement to capture, store, manage, share, and analyze video and other digital evidence. This segment also offers body cameras, in-car cameras, other hardware sensors, warranties on sensors, and other products, as well as professional services. The TASER segment engages in the development, manufacture, and sale of conducted energy devices (CEDs) under the TASER brand; manufacture and sale of CEDs, batteries, accessories and extended warranties, digital subscription training content, and virtual reality (VR) training content, as well as other professional services related to TASER and VR deployments. The company serves first responders across international, federal, state, and local law enforcement; and fire, corrections, and emergency medical services, as well as justice sector, commercial enterprises, and consumers through online store, distribution partners, and third-party resellers. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 124.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -6.29 > 1.0 |
| NWC/Revenue: 80.69% < 20% (prev 29.75%; Δ 50.94% < -1%) |
| CFO/TA 0.03 > 3% & CFO 211.3m > Net Income 124.9m |
| Net Debt (708.5m) to EBITDA (262.7m): 2.70 < 3 |
| Current Ratio: 2.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (100.0m) vs 12m ago 23.32% < -2% |
| Gross Margin: 59.66% > 18% (prev 0.60%; Δ 5906 % > 0.5%) |
| Asset Turnover: 48.45% > 50% (prev 46.54%; Δ 1.90% > 0%) |
| Interest Coverage Ratio: 1.96 > 6 (EBITDA TTM 262.7m / Interest Expense TTM 94.2m) |
Altman Z'' 3.01
| A: 0.32 (Total Current Assets 3.71b - Total Current Liabilities 1.47b) / Total Assets 7.00b |
| B: 0.13 (Retained Earnings 936.7m / Total Assets 7.00b) |
| C: 0.03 (EBIT TTM 184.4m / Avg Total Assets 5.74b) |
| D: 0.25 (Book Value of Equity 924.9m / Total Liabilities 3.76b) |
| Altman-Z'' Score: 3.01 = A |
Beneish M -2.99
| DSRI: 0.78 (Receivables 955.7m/915.5m, Revenue 2.78b/2.08b) |
| GMI: 1.00 (GM 59.66% / 59.61%) |
| AQI: 0.98 (AQ_t 0.42 / AQ_t-1 0.43) |
| SGI: 1.33 (Revenue 2.78b / 2.08b) |
| TATA: -0.01 (NI 124.9m - CFO 211.3m) / TA 7.00b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of AXON shares?
As of March 01, 2026, the stock is trading at USD 542.40 with a total of 1,498,987 shares traded.
Over the past week, the price has changed by +25.00%, over one month by -11.11%, over three months by +0.42% and over the past year by +3.23%.
Over the past week, the price has changed by +25.00%, over one month by -11.11%, over three months by +0.42% and over the past year by +3.23%.
Is AXON a buy, sell or hold?
Axon Enterprise has received a consensus analysts rating of 4.24.
Therefore, it is recommended to buy AXON.
- StrongBuy: 7
- Buy: 7
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AXON price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 747.8 | 37.9% |
| Analysts Target Price | 747.8 | 37.9% |
AXON Fundamental Data Overview February 27, 2026
P/E Trailing = 164.0946
P/E Forward = 84.7458
P/S = 14.8664
P/B = 20.7015
P/EG = 2.86
Revenue TTM = 2.78b USD
EBIT TTM = 184.4m USD
EBITDA TTM = 262.7m USD
Long Term Debt = 1.73b USD (from longTermDebt, two quarters ago)
Short Term Debt = 80.6m USD (from shortTermDebt, last quarter)
Debt = 1.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 708.5m USD (from netDebt column, last quarter)
Enterprise Value = 41.52b USD (41.32b + Debt 1.91b - CCE 1.71b)
Interest Coverage Ratio = 1.96 (Ebit TTM 184.4m / Interest Expense TTM 94.2m)
EV/FCF = 553.1x (Enterprise Value 41.52b / FCF TTM 75.1m)
FCF Yield = 0.18% (FCF TTM 75.1m / Enterprise Value 41.52b)
FCF Margin = 2.70% (FCF TTM 75.1m / Revenue TTM 2.78b)
Net Margin = 4.49% (Net Income TTM 124.9m / Revenue TTM 2.78b)
Gross Margin = 59.66% ((Revenue TTM 2.78b - Cost of Revenue TTM 1.12b) / Revenue TTM)
Gross Margin QoQ = 57.90% (prev 60.14%)
Tobins Q-Ratio = 5.93 (Enterprise Value 41.52b / Total Assets 7.00b)
Interest Expense / Debt = 1.51% (Interest Expense 28.8m / Debt 1.91b)
Taxrate = 40.00% (2.00m / 5.00m)
NOPAT = 110.7m (EBIT 184.4m * (1 - 40.00%))
Current Ratio = 2.53 (Total Current Assets 3.71b / Total Current Liabilities 1.47b)
Debt / Equity = 0.59 (Debt 1.91b / totalStockholderEquity, last quarter 3.24b)
Debt / EBITDA = 2.70 (Net Debt 708.5m / EBITDA 262.7m)
Debt / FCF = 9.44 (Net Debt 708.5m / FCF TTM 75.1m)
Total Stockholder Equity = 2.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.18% (Net Income 124.9m / Total Assets 7.00b)
RoE = 4.32% (Net Income TTM 124.9m / Total Stockholder Equity 2.89b)
RoCE = 3.99% (EBIT 184.4m / Capital Employed (Equity 2.89b + L.T.Debt 1.73b))
RoIC = 2.32% (NOPAT 110.7m / Invested Capital 4.78b)
WACC = 11.32% (E(41.32b)/V(43.23b) * Re(11.80%) + D(1.91b)/V(43.23b) * Rd(1.51%) * (1-Tc(0.40)))
Discount Rate = 11.80% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 14.57%
[DCF] Terminal Value 71.25% ; FCFF base≈176.9m ; Y1≈218.2m ; Y5≈371.6m
[DCF] Fair Price = 38.02 (EV 3.73b - Net Debt 708.5m = Equity 3.02b / Shares 79.4m; r=11.32% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 90.67 | EPS CAGR: 51.75% | SUE: 1.71 | # QB: 1
Revenue Correlation: 99.81 | Revenue CAGR: 35.30% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.56 | Chg7d=-0.031 | Chg30d=-0.031 | Revisions Net=-1 | Analysts=17
EPS current Year (2026-12-31): EPS=7.82 | Chg7d=+0.246 | Chg30d=+0.277 | Revisions Net=-1 | Growth EPS=+14.1% | Growth Revenue=+28.4%
EPS next Year (2027-12-31): EPS=10.43 | Chg7d=+0.659 | Chg30d=+0.767 | Revisions Net=+1 | Growth EPS=+33.4% | Growth Revenue=+28.9%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 11.2% (Discount Rate 11.8% - Earnings Yield 0.6%)
[Growth] Growth Spread = +17.8% (Analyst 29.0% - Implied 11.2%)
P/E Forward = 84.7458
P/S = 14.8664
P/B = 20.7015
P/EG = 2.86
Revenue TTM = 2.78b USD
EBIT TTM = 184.4m USD
EBITDA TTM = 262.7m USD
Long Term Debt = 1.73b USD (from longTermDebt, two quarters ago)
Short Term Debt = 80.6m USD (from shortTermDebt, last quarter)
Debt = 1.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 708.5m USD (from netDebt column, last quarter)
Enterprise Value = 41.52b USD (41.32b + Debt 1.91b - CCE 1.71b)
Interest Coverage Ratio = 1.96 (Ebit TTM 184.4m / Interest Expense TTM 94.2m)
EV/FCF = 553.1x (Enterprise Value 41.52b / FCF TTM 75.1m)
FCF Yield = 0.18% (FCF TTM 75.1m / Enterprise Value 41.52b)
FCF Margin = 2.70% (FCF TTM 75.1m / Revenue TTM 2.78b)
Net Margin = 4.49% (Net Income TTM 124.9m / Revenue TTM 2.78b)
Gross Margin = 59.66% ((Revenue TTM 2.78b - Cost of Revenue TTM 1.12b) / Revenue TTM)
Gross Margin QoQ = 57.90% (prev 60.14%)
Tobins Q-Ratio = 5.93 (Enterprise Value 41.52b / Total Assets 7.00b)
Interest Expense / Debt = 1.51% (Interest Expense 28.8m / Debt 1.91b)
Taxrate = 40.00% (2.00m / 5.00m)
NOPAT = 110.7m (EBIT 184.4m * (1 - 40.00%))
Current Ratio = 2.53 (Total Current Assets 3.71b / Total Current Liabilities 1.47b)
Debt / Equity = 0.59 (Debt 1.91b / totalStockholderEquity, last quarter 3.24b)
Debt / EBITDA = 2.70 (Net Debt 708.5m / EBITDA 262.7m)
Debt / FCF = 9.44 (Net Debt 708.5m / FCF TTM 75.1m)
Total Stockholder Equity = 2.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.18% (Net Income 124.9m / Total Assets 7.00b)
RoE = 4.32% (Net Income TTM 124.9m / Total Stockholder Equity 2.89b)
RoCE = 3.99% (EBIT 184.4m / Capital Employed (Equity 2.89b + L.T.Debt 1.73b))
RoIC = 2.32% (NOPAT 110.7m / Invested Capital 4.78b)
WACC = 11.32% (E(41.32b)/V(43.23b) * Re(11.80%) + D(1.91b)/V(43.23b) * Rd(1.51%) * (1-Tc(0.40)))
Discount Rate = 11.80% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 14.57%
[DCF] Terminal Value 71.25% ; FCFF base≈176.9m ; Y1≈218.2m ; Y5≈371.6m
[DCF] Fair Price = 38.02 (EV 3.73b - Net Debt 708.5m = Equity 3.02b / Shares 79.4m; r=11.32% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 90.67 | EPS CAGR: 51.75% | SUE: 1.71 | # QB: 1
Revenue Correlation: 99.81 | Revenue CAGR: 35.30% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.56 | Chg7d=-0.031 | Chg30d=-0.031 | Revisions Net=-1 | Analysts=17
EPS current Year (2026-12-31): EPS=7.82 | Chg7d=+0.246 | Chg30d=+0.277 | Revisions Net=-1 | Growth EPS=+14.1% | Growth Revenue=+28.4%
EPS next Year (2027-12-31): EPS=10.43 | Chg7d=+0.659 | Chg30d=+0.767 | Revisions Net=+1 | Growth EPS=+33.4% | Growth Revenue=+28.9%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 11.2% (Discount Rate 11.8% - Earnings Yield 0.6%)
[Growth] Growth Spread = +17.8% (Analyst 29.0% - Implied 11.2%)